European officials told Reuters that the new legal action, launched on Tuesday by the European Commission, concerned the merits of the case against AstraZeneca and would allow the European Union to pursue financial penalties. Yesterday, a spokesman for the European Commission said “the merits [of the proposed lawsuit] will be …
Read More »